This inventor holds 24 USPTO granted patents and 7 published patent applications, plus 6 CIPO patents and 6 EPO patents, primarily in Hepatitis C Research. Top assignees: Toray Industries, Inc., Tokyo Metropolitan Institute of Medical Science, National Institute of Infectious Diseases. Active years: 2000-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Winchester, MA (US) (2001 - 2004)
- Tokyo, JP (2000 - 2016)
Company Filing History:
18 out of 3,586 
10 out of 56 
9 out of 37 
Years Active: 2000-2016
Areas of Expertise:
Title: The Innovations of Takaji Wakita: A Pioneering Inventor in Hepatitis C Research
Introduction: Takaji Wakita is a prominent inventor based in Tokyo, Japan, whose contributions to medical science, particularly in the field of hepatitis C, are noteworthy. With a total of 24 patents to his name, Wakita's work focuses on revolutionary nucleic acid constructs and their applications in understanding and combating the hepatitis C virus.
Latest Patents: Among Wakita's latest innovations, two significant patents stand out. The first is a nucleic acid construct derived from the genome of hepatitis C virus genotype 3a. This construct showcases a meticulously structured nucleotide sequence that includes a 5' untranslated region, various nucleotide sequences coding for critical proteins such as NS3, NS4A, NS4B, NS5A, and NS5B, along with a 3' untranslated region. The second patent involves a nucleic acid construct from the hepatitis C virus genome of genotype 1B, which details a subgenomic replicon RNA and full genomic replicon RNA. These RNA constructs possess the ability to autonomously replicate and produce infectious hepatitis C virus particles, marking a significant advancement in viral research.
Career Highlights: Takaji Wakita has made substantial contributions to the scientific community through his tenure at notable institutions. He has worked with Toray Industries, Inc., and the Tokyo Metropolitan Institute of Medical Science, where he engaged in pivotal research related to viral genomics and infectious diseases. His innovative approaches have not only contributed to patent filings but have also paved the way for advancements in medical science.
Collaborations: Throughout his illustrious career, Wakita has collaborated with esteemed colleagues, including Tomoko Date and Takanobu Kato. These partnerships have facilitated the sharing of insights and expertise, further enriching his research and innovation endeavors in the field of hepatitis C.
Conclusion: Takaji Wakita's relentless pursuit of knowledge and his innovative contributions to hepatitis C research underscore his significance as an inventor. With 24 patents bearing his name, his work is poised to have a lasting impact on medical science, providing vital tools and insights into the fight against hepatitis C virus infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile